A conformationally defined 6-s-trans-retinoic acid isomer: synthesis, chemopreventive activity, and toxicity. 1994

M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
Department of Chemistry, University of Alabama at Birmingham 35294.

A conformationally defined retinoic acid analog (1) which contains a dimethylene bridge to maintain the 6-s-trans orientation for two terminal double bonds in the polyene chain was synthesized. A Reformatsky reaction was utilized to extend the polyene chain of the starting enone, which provided exclusively the 9Z-configuration for the intermediate aldehyde. A Horners-Emmons condensation with this aldehyde then produced retinoic acid analogs with both 9Z- and 9Z,13Z-configurations. An I2-catalyzed isomerization of the intermediate 9Z-aldehyde yielded the all-E-aldehyde, which was olefinated as above to yield the (all-E)- and (13Z)-retinoic acid analogs of 1. Each configurational isomer of 1 was evaluated for its ability to inhibit the binding of retinoic acid to CRABP (chick skin) and to inhibit the chemical induction of ornithine decarboxylase in mouse skin. In each assay (all-E)-1 was the most active isomer, and this activity was comparable to or better than that for (all-E)-retinoic acid. (all-E)-1 and (13Z)-1 were both shown to be equally effective as (13Z)-retinoic acid in suppressing the proliferation of human sebaceous cells in vitro. (all-E)-1 was further evaluated for its ability to prevent the induction of mouse skin papillomas and to induce signs of vitamin A toxicity in mice. The cancer chemopreventive activity of (all-E)-1 was comparable to that of (all-E)-retinoic acid, and the toxicity was comparable to or slightly better than that of the natural vitamin.

UI MeSH Term Description Entries
D009955 Ornithine Decarboxylase A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. Ornithine Carboxy-lyase,Carboxy-lyase, Ornithine,Decarboxylase, Ornithine,Ornithine Carboxy lyase
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D016475 3T3 Cells Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION. 3T3 Cell,Cell, 3T3,Cells, 3T3

Related Publications

M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
June 1995, Journal of medicinal chemistry,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
September 1992, European journal of haematology,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
February 1992, International journal of immunopharmacology,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
September 1980, Journal of medicinal chemistry,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
August 2003, Journal of medicinal chemistry,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
January 1989, Archives of toxicology,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
January 2014, Current topics in medicinal chemistry,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
August 2007, Molecular carcinogenesis,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
May 1998, Journal of medicinal chemistry,
M F Vaezi, and M Alam, and B P Sani, and T S Rogers, and L Simpson-Herren, and J J Wille, and D L Hill, and T I Doran, and W J Brouillette, and D D Muccio
March 1992, The Journal of antibiotics,
Copied contents to your clipboard!